Defymed
Nathalie Stiegler has a diverse work experience in office management and administrative roles. Nathalie started their career in 2017 as a Gerante at Agence NS, where they provided administrative services to various businesses and professionals. In 2018, they joined CardioRenal as an Administrative Office Manager, a position they held until December 2021. Throughout their career, Nathalie also worked as an Office Manager at several companies, including dianosic, Keydiag, Kwit, RDS (Rhythm Diagnostic Systems), and VIJUMP. Nathalie demonstrated their organizational and administrative skills in these roles. Nathalie'swork experience also includes serving as an Administrative Office Manager at SC MEDICA, HypnoVR, and Defymed. Nathalie has a strong background in office management and has gained valuable experience in various industries.
Nathalie Stiegler began their education in 1996 at IFCE, where they pursued a BTS Assistante de gestion PME-PMI degree in the field of Administration/gestion des petites entreprises. Nathalie completed their studies in 1998. Then, in 2016, they attended Candice Mack and obtained a CQP Maquilleur conseil animateur degree. The field of study for this degree is not specified.
This person is not in any teams
Defymed
Defymed is a worldwide leader in the development of innovative implantable medical devices that change the paradigm of therapeutics' administration. Defymed's innovations were developed to limit adverse events related to current standard of care based on site specific delivery of therapeutics. Our solutions aim for a preciseadministration of drugs, in a physiologic site, in order to improve disease's management and patients' quality of life. Up to date, two first in class technologies were developed by Defymed: MailPan®, a physiologic cell encapsulation device, and ExOlin®, a targeted drug delivery device. Defymed owns an exclusive technology and know-how which positions its medical devices as a platform to meet several therapeutic applications, among which type 1 diabetes, hemophilia and cancer management. Defymed is certified ISO13485:2016.Defymed relies also on a strong and unique worldwide network gathering experts from the cell therapy and drug delivery fields. Defymed has been rewarded several times in Europe and in the USA, for its unique approaches to reinvent patients' journey.